Literature DB >> 17198805

Reverse right ventricular remodeling after pulmonary endarterectomy.

Andrea M D'Armini1, Giorgio Zanotti, Stefano Ghio, Giulia Magrini, Matteo Pozzi, Laura Scelsi, Giulia Meloni, Catherine Klersy, Mario Viganò.   

Abstract

OBJECTIVES: We sought to evaluate the capability of the right ventricle to regain normal morphology and function after pulmonary endarterectomy, to correlate right ventricular reverse remodeling with functional status, and to identify independent predictors of clinical failure after surgical intervention.
METHODS: From December 2000 through August 2003, 45 patients underwent isolated pulmonary endarterectomy. Morphology and function of the right ventricle were studied by using a combination of right heart catheterization, cardiac magnetic resonance, and transthoracic echocardiography. Functional status was evaluated by using New York Heart Association class. Full preoperative data were available for 37 candidates. All patients were evaluated before discharge, at 3 months, and at 1, 2, and 3 years postoperatively using the same modalities.
RESULTS: Immediately after surgical intervention, right ventricular cavitary dimensions decreased significantly, and tricuspid regurgitation radically improved. Right ventricular ejection fraction and functional status improved and right ventricular hypertrophy reversed over a longer time period. Higher ventricular dimensions and lower ejection fraction of the right ventricle were associated with poorer functional status at any time postoperatively. At discharge, pulmonary vascular resistance of greater than 509 dyne x sec x cm(-5) and right ventricular ejection fraction of 24% or less predicted clinical failure at 12 months' follow-up.
CONCLUSIONS: After pulmonary endarterectomy, the right ventricle recovers and maintains normal architecture and function over time, regardless of the severity of preoperative disease. Accurate preoperative evaluation of the hemodynamics and anatomy of the thromboembolic lesions are mandatory. If pulmonary endarterectomy is not expected to decrease pulmonary vascular resistance to less than 509 dyne x sec x cm(-5), indication for surgical intervention needs to be carefully evaluated.

Entities:  

Mesh:

Year:  2006        PMID: 17198805     DOI: 10.1016/j.jtcvs.2006.08.059

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  17 in total

1.  The importance of trabecular hypertrophy in right ventricular adaptation to chronic pressure overload.

Authors:  Mariëlle C van de Veerdonk; Sophie A Dusoswa; J Tim Marcus; Harm-Jan Bogaard; Onno Spruijt; Taco Kind; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  Int J Cardiovasc Imaging       Date:  2013-12-04       Impact factor: 2.357

2.  Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.

Authors:  John E Cannon; Li Su; David G Kiely; Kathleen Page; Mark Toshner; Emilia Swietlik; Carmen Treacy; Anie Ponnaberanam; Robin Condliffe; Karen Sheares; Dolores Taboada; John Dunning; Steven Tsui; Choo Ng; Deepa Gopalan; Nicholas Screaton; Charlie Elliot; Simon Gibbs; Luke Howard; Paul Corris; James Lordan; Martin Johnson; Andrew Peacock; Robert MacKenzie-Ross; Benji Schreiber; Gerry Coghlan; Kostas Dimopoulos; Stephen J Wort; Sean Gaine; Shahin Moledina; David P Jenkins; Joanna Pepke-Zaba
Journal:  Circulation       Date:  2016-04-06       Impact factor: 29.690

Review 3.  Management of pulmonary hypertension and right heart failure in the intensive care unit.

Authors:  Jonathan Grinstein; Mardi Gomberg-Maitland
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

4.  Cardiovascular magnetic resonance in pulmonary hypertension.

Authors:  William M Bradlow; J Simon R Gibbs; Raad H Mohiaddin
Journal:  J Cardiovasc Magn Reson       Date:  2012-01-18       Impact factor: 5.364

5.  Brazilian Thoracic Society recommendations for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension.

Authors:  Caio Julio Cesar Dos Santos Fernandes; Jaquelina Sonoe Ota-Arakaki; Frederico Thadeu Assis Figueiredo Campos; Ricardo de Amorim Correa; Marcelo Basso Gazzana; Carlos Vianna Poyares Jardim; Fábio Biscegli Jatene; Jose Leonidas Alves Junior; Roberta Pulcheri Ramos; Daniela Tannus; Carlos Teles; Mario Terra Filho; Daniel Waetge; Rogerio Souza
Journal:  J Bras Pneumol       Date:  2022-06-24       Impact factor: 2.800

6.  Cardiac MRI in pulmonary artery hypertension: correlations between morphological and functional parameters and invasive measurements.

Authors:  Jean-Philippe Alunni; Bruno Degano; Catherine Arnaud; Laurent Tétu; Nathalie Blot-Soulétie; Alain Didier; Philippe Otal; Hervé Rousseau; Valérie Chabbert
Journal:  Eur Radiol       Date:  2010-01-22       Impact factor: 5.315

7.  Time course of reversed cardiac remodeling after pulmonary endarterectomy in patients with chronic pulmonary thromboembolism.

Authors:  Misako Iino; Steven Dymarkowski; Lertlak Chaothawee; Marion Delcroix; Jan Bogaert
Journal:  Eur Radiol       Date:  2007-12-20       Impact factor: 5.315

8.  Effects of pulmonary endarterectomy on pulmonary hemodynamics in chronic thromboembolic pulmonary hypertension, evaluated by interventricular septum curvature.

Authors:  Takahiko Saito; Hajime Kasai; Toshihiko Sugiura; Yukiko Takahashi; Hiroshi Tajima; Ayako Shigeta; Seiichiro Sakao; Nobuhiro Tanabe; Koichiro Tatsumi
Journal:  Pulm Circ       Date:  2020-03-13       Impact factor: 3.017

9.  Right ventricular reverse remodeling after pulmonary endarterectomy: magnetic resonance imaging and clinical and right heart catheterization assessment.

Authors:  Marius Berman; Deepa Gopalan; Linda Sharples; Nick Screaton; Caroline Maccan; Karen Sheares; Joanna Pepke-Zaba; John Dunning; Steven Tsui; David P Jenkins
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

10.  Pulmonary endarterectomy normalizes interventricular dyssynchrony and right ventricular systolic wall stress.

Authors:  Gert-Jan Mauritz; Anton Vonk-Noordegraaf; Taco Kind; Sulaiman Surie; Jaap J Kloek; Paul Bresser; Nabil Saouti; Joachim Bosboom; Nico Westerhof; J Tim Marcus
Journal:  J Cardiovasc Magn Reson       Date:  2012-01-12       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.